ALISO VIEJO, Calif.
Oct. 23, 2013
Avanir Pharmaceuticals, Inc.
(NASDAQ: AVNR) will host a live webcast in conjunction with its Investor Relations Day on
Tuesday, October 29, 2013
12:30 p.m. ET
New York City
To view and listen to the webcast please visit our website at
. Visitors will also be able to view and listen to an archive copy of the webcast found in the Investor Relations section of
. The archive will be available for 30 days following the event.
For more information on the Investor Relations Day please refer to contact information within this press release.
About Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit
AVANIR® is a trademark or registered trademark of Avanir Pharmaceuticals, Inc. in
the United States
and other countries.
2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.
Avanir Investor & Media Contact
+1 (949) 389-6700
Burns McClellan Contact
+1 (212) 213-0006
SOURCE Avanir Pharmaceuticals, Inc.